Post by kickingfrog on Oct 23, 2016 8:47:11 GMT
...ID 35 Stakeholder CUK (page 15 of 18)
...Having a statement requiring provision of information alone about the gluten-free foods available on prescription is
not enough to address the inequality in provision of gluten-free food on prescription across England. There is
variation in the amount and type of gluten-free food available on prescription depending on the policy implemented by
the local clinical commissioning group (CCG) in England. Currently, 30% of CCGs have restricted or completely
removed access to Advisory Committee on Borderline Substances (ACBS) approved products on prescription (as
mentioned in the consultation documentation under Definition of Terms on page 20). The quality standard should
address this potential for variation in provision by having a mandate for a minimum level of support which should be
provided by all CCGs.....
www.nice.org.uk/guidance/QS134/documents/consultation-summary-report
...Having a statement requiring provision of information alone about the gluten-free foods available on prescription is
not enough to address the inequality in provision of gluten-free food on prescription across England. There is
variation in the amount and type of gluten-free food available on prescription depending on the policy implemented by
the local clinical commissioning group (CCG) in England. Currently, 30% of CCGs have restricted or completely
removed access to Advisory Committee on Borderline Substances (ACBS) approved products on prescription (as
mentioned in the consultation documentation under Definition of Terms on page 20). The quality standard should
address this potential for variation in provision by having a mandate for a minimum level of support which should be
provided by all CCGs.....
www.nice.org.uk/guidance/QS134/documents/consultation-summary-report